M1 Kliniken AG
M1 Kliniken AG Fundamental Analysis
M1 Kliniken AG (MKLNF) shows moderate financial fundamentals with a PE ratio of 8.43, profit margin of 6.08%, and ROE of 18.60%. The company generates $0.4B in annual revenue with moderate year-over-year growth of 7.23%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 62.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze MKLNF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentMKLNF demonstrates superior asset utilization.
Valuation Score
ExcellentMKLNF trades at attractive valuation levels.
Growth Score
ExcellentMKLNF delivers strong and consistent growth momentum.
Financial Health Score
ExcellentMKLNF maintains a strong and stable balance sheet.
Profitability Score
ModerateMKLNF maintains healthy but balanced margins.
Key Financial Metrics
Is MKLNF Expensive or Cheap?
P/E Ratio
MKLNF trades at 8.43 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, MKLNF's PEG of 0.25 indicates potential undervaluation.
Price to Book
The market values M1 Kliniken AG at 1.56 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.40 times EBITDA. This is generally considered low.
How Well Does MKLNF Make Money?
Net Profit Margin
For every $100 in sales, M1 Kliniken AG keeps $6.08 as profit after all expenses.
Operating Margin
Core operations generate 9.49 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.60 in profit for every $100 of shareholder equity.
ROA
M1 Kliniken AG generates $11.69 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
M1 Kliniken AG generates limited operating cash flow of $33.36M, signaling weaker underlying cash strength.
Free Cash Flow
M1 Kliniken AG produces free cash flow of $33.25M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $1.82 in free cash annually.
FCF Yield
MKLNF converts 18.30% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
8.43
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.25
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.56
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.51
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.09
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.82
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.19
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How MKLNF Stacks Against Its Sector Peers
| Metric | MKLNF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 8.43 | 29.38 | Better (Cheaper) |
| ROE | 18.60% | 739.00% | Weak |
| Net Margin | 6.08% | -53619.00% (disorted) | Weak |
| Debt/Equity | 0.09 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 2.82 | 4.03 | Strong Liquidity |
| ROA | 11.69% | -20116.00% (disorted) | Strong |
MKLNF outperforms its industry in 4 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews M1 Kliniken AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
314.28%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
55.28%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
917.43%
Industry Style: Defensive, Growth, Innovation
High Growth